Circulating tumor cells and breast cancer-specific mutations in primary breast cancer.
BRCA1/2
circulating tumor cells
epithelial-to-mesenchymal transition
primary breast cancer
targeted resequencing
Journal
Molecular and clinical oncology
ISSN: 2049-9450
Titre abrégé: Mol Clin Oncol
Pays: England
ID NLM: 101613422
Informations de publication
Date de publication:
Jun 2020
Jun 2020
Historique:
received:
20
02
2019
accepted:
29
01
2020
entrez:
28
4
2020
pubmed:
28
4
2020
medline:
28
4
2020
Statut:
ppublish
Résumé
Circulating tumor cells (CTCs) play a pivotal role in tumor dissemination and progression, and are considered to be a critical part of the metastatic cascade. The aim of the present research article was to examine breast cancer-specific mutations in primary breast cancer (PBC) using targeted resequencing. A total of 78 patients with PBC were enrolled into this translational study. Reverse transcription-quantitative PCR assay for the expression of epithelial markers (
Identifiants
pubmed: 32337039
doi: 10.3892/mco.2020.2026
pii: MCO-0-0-2026
pmc: PMC7179389
doi:
Types de publication
Journal Article
Langues
eng
Pagination
565-573Informations de copyright
Copyright © 2020, Spandidos Publications.
Références
Clin Cancer Res. 2008 May 1;14(9):2593-600
pubmed: 18451221
Br J Cancer. 2009 Jun 16;100(12):1917-25
pubmed: 19455139
Anticancer Res. 2017 May;37(5):2727-2734
pubmed: 28476852
Anticancer Res. 2019 Apr;39(4):1829-1837
pubmed: 30952723
Breast Cancer Res. 2011 Jun 15;13(3):R67
pubmed: 21699723
Science. 2013 Feb 1;339(6119):580-4
pubmed: 23372014
Breast J. 2015 Mar-Apr;21(2):155-60
pubmed: 25623304
Breast Cancer Res Treat. 2017 Jun;163(2):219-230
pubmed: 28271309
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Science. 2003 Oct 24;302(5645):643-6
pubmed: 14576434
Oncologist. 2016 Sep;21(9):1063-78
pubmed: 27384237
Nat Rev Cancer. 2008 Apr;8(4):253-67
pubmed: 18354415
N Engl J Med. 2004 Aug 19;351(8):781-91
pubmed: 15317891
Nature. 2012 May 16;486(7403):400-4
pubmed: 22722201
J Natl Cancer Inst. 1970 Oct;45(4):773-82
pubmed: 5513503
Clin Cancer Res. 2018 Mar 15;24(6):1486-1499
pubmed: 29311117
J Clin Invest. 2009 Jun;119(6):1420-8
pubmed: 19487818
PLoS Med. 2016 Dec 27;13(12):e1002201
pubmed: 28027327
Oncotarget. 2017 Sep 21;8(49):85680-85691
pubmed: 29156750
BMC Cancer. 2010 Apr 16;10:145
pubmed: 20398395
Nature. 2012 Oct 4;490(7418):61-70
pubmed: 23000897
Cell. 2009 Dec 24;139(7):1315-26
pubmed: 20064377
Lancet Oncol. 2012 Jul;13(7):688-95
pubmed: 22677156
Mol Med Rep. 2017 May;15(5):2957-2968
pubmed: 28358430
Cancer. 2008 Nov 1;113(9):2422-30
pubmed: 18785255
Cell Biol Int. 2002;26(5):463-76
pubmed: 12095232
Cells Tissues Organs. 2005;179(1-2):11-23
pubmed: 15942189
Int J Cancer. 2012 Feb 15;130(4):808-16
pubmed: 21387303
Dev Cell. 2008 Jun;14(6):818-29
pubmed: 18539112
Nat Rev Clin Oncol. 2010 Dec;7(12):693-701
pubmed: 20956980
Nucleic Acids Res. 2001 May 1;29(9):e45
pubmed: 11328886
Cancer Res. 2018 Feb 15;78(4):1110-1122
pubmed: 29233927
Clin Cancer Res. 2012 Oct 15;18(20):5701-10
pubmed: 22908097
Gene. 2015 Feb 10;556(2):163-9
pubmed: 25445393
BMC Cancer. 2014 Jun 28;14:472
pubmed: 24972610
Clin Transl Oncol. 2016 Mar;18(3):322-30
pubmed: 26260915
J Clin Oncol. 1996 Aug;14(8):2197-205
pubmed: 8708708